Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      WHO agrees watered down resolution for clearer drug prices

      WHO agrees watered down resolution for clearer drug prices

      Medical Dialogues Bureau29 May 2019 9:00 AM IST
      It was hailed as a landmark by WHO chief Tedros Adhanom Ghebreyesus and "enthusiastically welcomed" by the United States, which had advocated making...
      Manufacturers illegally marketing unauthorized diabetes management devices; USFDA issues warning

      Manufacturers illegally marketing unauthorized diabetes management devices; USFDA issues warning

      Medical Dialogues Bureau28 May 2019 10:03 AM IST
      As per the agency note, the USFDA is aware of manufacturers illegally marketing unauthorized devices for diabetes management, which have not been...
      Pfizer epilepsy drug Lyrica fails in phase III trial

      Pfizer epilepsy drug Lyrica fails in phase III trial

      Medical Dialogues Bureau28 May 2019 9:00 AM IST
      New Delhi: Pfizer Inc. recently announced that a Phase 3 study to assess the use of LYRICA (pregabalin) as adjunctive therapy for epilepsy patients 5...
      Amazon offers $25 gift cards to users in exchange of taking 3D scan of their body

      Amazon offers $25 gift cards to users in exchange of taking 3D scan of their body

      Medical Dialogues Bureau27 May 2019 9:15 AM IST
      It is unclear as to how the study results will be used but Amazon says it is to learn about diversity among body shapes and the data will be used for...
      Teva Pharma to settle $85 million opioid claims of Oklahoma

      Teva Pharma to settle $85 million opioid claims of Oklahoma

      Medical Dialogues Bureau27 May 2019 9:00 AM IST
      Oklahoma Attorney General Mike Hunter has alleged that JnJ and Teva Pharma, along with OxyContin maker Purdue Pharma LP, carried out deceptive marking...
      WHO drug pricing talks may fail to end secrecy, activists fear

      WHO drug pricing talks may fail to end secrecy, activists fear

      Medical Dialogues Bureau26 May 2019 9:00 AM IST
      GENEVA: Governments are working on a drug pricing transparency deal at the World Health Organization's (WHO) annual assembly, but activists said on...
      US impose sanctions on network of online pharmacies for opioids

      US impose sanctions on network of online pharmacies for opioids

      Medical Dialogues Bureau25 May 2019 9:15 AM IST
      The move was the latest effort by the Trump Administration to tackle the U.S. epidemic of abuse and overdoses linked to prescription painkillers and...
      Array BioPharmas colorectal cancer combo treatment meets main goals

      Array BioPharma's colorectal cancer combo treatment meets main goals

      Medical Dialogues Bureau25 May 2019 9:00 AM IST
      U.S: Array BioPharma Inc's cocktail of three therapies helped patients with a type of colorectal cancer live longer than those on standard treatment,...
      China M&A crimp due to data quality, lagging regulatory standards; says Novartis CEO

      China M&A crimp due to data quality, lagging regulatory standards; says Novartis CEO

      Medical Dialogues Bureau24 May 2019 9:00 AM IST
      Novartis has 14 medicines listed in China, including top-selling psoriasis and arthritis medicine Cosentyx, a development helped as Chinese regulators...
      Novartis plans gene therapy price lower than $4 million to $5 million range

      Novartis plans gene therapy price lower than $4 million to $5 million range

      Medical Dialogues Bureau23 May 2019 9:00 AM IST
      Novartis has previously said it could price the treatment in a range of $1.5 million to $5 million.BOSTON: Novartis AG's top executive said on...
      Supreme Court sends back Merck Fosamax lawsuit to lower court

      Supreme Court sends back Merck Fosamax lawsuit to lower court

      Medical Dialogues Bureau21 May 2019 9:15 AM IST
      Users of Fosamax, which is prescribed to treat osteoporosis in women who have gone through menopause, had sued to argue that Merck had failed to...
      Investors keep food firms on warning over antibiotics

      Investors keep food firms on warning over antibiotics

      Medical Dialogues Bureau21 May 2019 9:00 AM IST
      Resistance to antibiotics has been flagged as a major risk to public health and economic growth by policymakers and the investor action formed part of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok